Increased Serum LIGHT Levels Correlate with Disease Progression and Severity of Interstitial Pneumonia in Patients with Dermatomyositis: A Case Control Study.
Activated CD8+ T cells play an important role in the pathogenesis of dermatomyositis (DM) with interstitial pneumonia (IP). Serum CD8+ T-cell activator, LIGHT, and Th1/Th2/Th17 cytokines were measured in DM-IP patients and compared with clinical parameters to investigate their usefulness.The correla...
Main Authors: | Takuya Kotani, Tohru Takeuchi, Takaaki Ishida, Ryota Masutani, Kentaro Isoda, Kenichiro Hata, Shuzo Yoshida, Shigeki Makino, Toshiaki Hanafusa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4598117?pdf=render |
Similar Items
-
Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study
by: Katsuhiro Oda, et al.
Published: (2017-05-01) -
Pre-treatment ferritin level and alveolar-arterial oxygen gradient can predict mortality rate due to acute/subacute interstitial pneumonia in dermatomyositis treated by cyclosporine a/glucocorticosteroid combination therapy: a case control study [corrected].
by: Kentaro Isoda, et al.
Published: (2014-01-01) -
Successful Treatment of Long-Term Severe Progressive Interstitial Pneumonia with Low-Dose Corticosteroid and Azathioprine in a Patient with Diffuse Systemic Sclerosis
by: Takuya Kotani, et al.
Published: (2012-01-01) -
Correlation of increased serum leucine-rich α2-glycoprotein levels with disease prognosis, progression, and activity of interstitial pneumonia in patients with dermatomyositis: A retrospective study.
by: Takaaki Ishida, et al.
Published: (2020-01-01) -
Serum Levels of Matrix Metalloproteinase (MMP) 9, a Risk Factor for Acute Coronary Syndrome, Are Reduced Independently of Serum MMP-3 by Anti-TNF-α Antibody (Infliximab) Therapy in Patients With Rheumatoid Arthritis
by: Takuya Kotani, et al.
Published: (2012-01-01)